The Joint Committee on Vaccination and immunisation (JVCI) have given interim advice on who to prioritise for a third dose of the COVID-19 booster vaccine from September. Millions of the most vulnerable people to COVID-19 may be offered the booster vaccination to ensure they have protection through the winter against new coronavirus variants. The JVCI’s […]
The origins of seven types of kidney cancer, including several rare subtypes, have been identified by researchers at the Wellcome Sanger Institute, Great Ormond Street Hospital (GOSH), the Princess Máxima Center for Paediatric Oncology and Oncode Institute. The findings confirm that these cancers originated in developmental cells found in the foetus. The results from the […]
In this video interview from UroToday Dena Battle from KCCure, an American kidney cancer patient advocacy organisation, joins urologist Jaime Landman and oncologist Monty Pal to dispel common myths regarding the diagnosis and treatment of kidney cancer being observed in patient communities and to speak about what is driving this misinformation. Watch the video interview […]
Despite the advances in first-line treatments for metastatic renal cell carcinoma (RCC) over the past few years, new treatments are on the horizon. In a presentation at the European International Kidney Cancer (EIKC) 2021 Virtual Annual Meeting, Dr Hans Hammers from University of Texas Southwestern Medical Center in the USA discussed future treatments for metastatic […]
Following suspensions by some countries of the COVID-19 Oxford AstraZeneca COVID-19 vaccine over suspected blood clots, the Medicines and Healthcare Regulatory Authority (MHRA) in the UK confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go and get their COVID-19 vaccine when asked to do so. Read […]
Cancer Research UK conducted a survey with cancer patients from across the UK to understand the impact of COVID-19 on their testing, treatment, and care, as well as their day-to-day lives and wellbeing. Nearly 2,000 people completed the survey in May 2020 to explore the impact of the COVID-19 pandemic on cancer patients. From this […]
Governments across the UK have bold ambitions to improve cancer survival and transform patients’ quality of life for the 1 in 2 of us who will be diagnosed with the disease. Decades of hard work have resulted in cancer survival doubling over the last half a century – now half of people diagnosed with cancer […]
Kidney cancers frequently have mutations in a gene called the von Hippel-Lindau (VHL) gene, resulting in high levels of a protein called hypoxia-inducible factor, or HIF-2α. This results in a number of changes in the cancer cells and their surrounding environment that favour tumour growth. The novel hypoxia-inducible factor 2α (HIF-2α) inhibitor, belzutifan (MK-6482), blocks […]
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the nivolumab plus cabozantinib combination for the first-line treatment of people with advanced renal cell carcinoma (RCC). The European Commission will now review the CHMP recommendation and make a final decision in the next few months […]
The NHS has teamed up with the police and security agencies to warn the public not to fall victim to con men trying to exploit the coronavirus vaccine campaign. England’s top GP has joined the head of Action Fraud, the National Crime Agency (NCA) and the National Cyber Security Centre (NCSC) in issuing joint advice […]
Copyright 2017 Kidney Cancer Support Network- Douglass Digital | Cambridge Web Design
